🇺🇸 FDA
Patent

US 8623894

Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamide

granted A61KA61K31/47A61K45/06

Quick answer

US patent 8623894 (Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamide) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/47, A61K45/06, A61P, A61P11/00